ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Pressure Builds On President To Sign Authorization Bill; No Movement Yet On Appropriations Measure

November 8, 1985

Procedures For Ending IGs Announced

July 10, 1992

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

February 24, 2006

Burton Clinic Shit Down Seven Year After PAHO Report

August 2, 1985

Study Section Members Likelier to Be Funded

August 1, 1986

DRG Reimbursement Schedules Estimated for High, Low Areas; City Of Hope Added to Exemptions, Other Without Much Hope

November 18, 1983